He Junwei, Xiao Yuhe, Wang Lu, Wang Zhaohui, Pan Jun, Bai Zunguang
The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Front Oncol. 2024 Jan 16;13:1280531. doi: 10.3389/fonc.2023.1280531. eCollection 2023.
Distant metastases of vulvar SCC most commonly involve the lung, liver, bone, skin, and lymph nodes. Metastasis from vulvar SCC to the kidneys is extremely rare, with only one case reported in the literature to date.
We report the case of a 53-year-old postmenopausal female patient was diagnosed with vulvar squamous cell carcinoma in an external hospital and following the diagnosis, she had been performed a vulvectomy for squamous cell carcinoma of the vulva, at that time, the patient had not undergone inguinal lymphadenectomy. In July 2019, she was admitted to our hospital due to upper right quadrant pain. An enhanced whole-body CT scan showed a mixed-density tumor of the right kidney with invasion into the right renal portal vein and multiple enlarged retroperitoneal lymph nodes. Positron emission tomography-computed tomography (PET - CT) scan showed a significantly increased radioactivity uptake in the tumor and enlarged lymph nodes, but PET-CT did not show abnormal enlargement of bilateral inguinal lymph nodes and no abnormal increase in radioactivity uptake. PET-CT examination did not show recurrence in terms of local of vulvar. These results led us to be gravely worried about possible renal carcinoma, so it was agreed upon to perform laparoscopic nephrectomy of the right kidney in the same month. Histology of the resected tumor confirmed it to be poorly differentiated squamous cell carcinoma with invasion consistent with metastatic vulvar carcinoma. Based on clinical history, radiological and histological facts, the patient was diagnosed with kidney metastasis from vulvar squamous cell carcinoma. Recovery from surgery went well and the patient was transferred to the oncology department and underwent a chemotherapy regimen consisting of paclitaxel and nedaplatin for further treatment. After 6 courses of chemotherapy. For a year after treatment, the patient had lived progression-free. Unfortunately, she died of tumor progression in July 2022.
Although renal metastasis from vulvar SCC is rare, renal metastasis should be considered for the patient with a history of vulvar cancer, whenever a mass is identified in the kidney. Timely surgical removal of renal metastasis may prolong the survival time.
外阴鳞状细胞癌的远处转移最常累及肺、肝、骨、皮肤和淋巴结。外阴鳞状细胞癌转移至肾脏极为罕见,迄今为止文献中仅报道过1例。
我们报告1例53岁绝经后女性患者,在外院被诊断为外阴鳞状细胞癌,诊断后接受了外阴鳞状细胞癌外阴切除术,当时患者未行腹股沟淋巴结清扫术。2019年7月,她因右上腹疼痛入住我院。增强全身CT扫描显示右肾有混合密度肿瘤,侵犯右肾门静脉,并有多个腹膜后淋巴结肿大。正电子发射断层扫描-计算机断层扫描(PET-CT)显示肿瘤及肿大淋巴结放射性摄取显著增加,但PET-CT未显示双侧腹股沟淋巴结异常肿大,也无放射性摄取异常增加。PET-CT检查未显示外阴局部复发。这些结果使我们非常担心可能是肾癌,因此当月同意行右肾腹腔镜肾切除术。切除肿瘤的组织学检查证实为低分化鳞状细胞癌,浸润情况符合转移性外阴癌。根据临床病史、影像学和组织学检查结果,该患者被诊断为外阴鳞状细胞癌肾转移。手术恢复顺利,患者转至肿瘤科,接受了由紫杉醇和奈达铂组成的化疗方案进行进一步治疗。化疗6个疗程后。治疗后1年,患者无进展生存。不幸的是,她于2022年7月死于肿瘤进展。
尽管外阴鳞状细胞癌肾转移罕见,但对于有外阴癌病史且肾脏发现肿块的患者,应考虑肾转移。及时手术切除肾转移灶可能延长生存时间。